IDEXX Laboratories, Inc.
IDXX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $288 | $454 | $113 | $144 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $561 | $530 | $491 | $426 |
| Inventory | $382 | $380 | $368 | $269 |
| Other Curr. Assets | $168 | $132 | $130 | $117 |
| Total Curr. Assets | $1,400 | $1,495 | $1,101 | $956 |
| Property Plant & Equip (Net) | $829 | $818 | $768 | $693 |
| Goodwill | $405 | $366 | $362 | $359 |
| Intangibles | $112 | $85 | $98 | $99 |
| Long-Term Investments | $58 | $56 | $56 | $19 |
| Tax Assets | $126 | $107 | $55 | $25 |
| Other NC Assets | $364 | $333 | $307 | $287 |
| Total NC Assets | $1,894 | $1,765 | $1,645 | $1,482 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,293 | $3,260 | $2,747 | $2,437 |
| Liabilities | – | – | – | – |
| Payables | $114 | $111 | $110 | $116 |
| Short-Term Debt | $439 | $345 | $674 | $168 |
| Tax Payable | $62 | $87 | $49 | $43 |
| Deferred Revenue | $34 | $37 | $38 | $40 |
| Other Curr. Liab. | $418 | $372 | $365 | $396 |
| Total Curr. Liab. | $1,068 | $952 | $1,236 | $764 |
| LT Debt | $548 | $723 | $796 | $863 |
| Deferred Rev, NC | $27 | $29 | $31 | $41 |
| Deferred Tax Liab, NC | $11 | $7 | $8 | $9 |
| Other NC Liab. | $44 | $66 | $68 | $71 |
| Total NC Liab. | $630 | $824 | $902 | $984 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $119 | $119 | $122 | $107 |
| Total Liabilities | $1,698 | $1,775 | $2,138 | $1,747 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $11 | $11 | $11 | $11 |
| Retained Earnings | $5,332 | $4,445 | $3,600 | $2,920 |
| AOCI | -$94 | -$71 | -$78 | -$53 |
| Other Equity | -$3,654 | -$2,900 | -$2,924 | -$2,188 |
| Total Equity | $1,595 | $1,485 | $609 | $690 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,293 | $3,260 | $2,747 | $2,437 |
| Net Debt | $699 | $613 | $1,357 | $887 |